Influenza Antigen Challenge Kit from Germany
Live attenuated influenza antigens for nasal challenge in immunity diagnostic studies. Classified in HTS 3006.30.10.00 as diagnostic reagents containing viral antigens administered directly to patients. Used in clinical trials for vaccine efficacy testing.
Duty Rate — Germany → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Select agent registration if H5N1 strains; FDA IND for trial use
• BSL-2 lab certification for handling; include challenge protocol
• Label clearly for 'clinical trial diagnostic use' to stay in 3006